Showing results (41-50 of 122) with videos related to
Sort By:
Pageof 13
Journal of Neuro-Oncology|August 30, 2017
Skin toxicities associated with tumor treating fields: case based reviewRimas V Lukas, Kelley L Ratermann, Eric T Wong, et al.Frontiers in Human Neuroscience|July 5, 2022
Guidelines for Burr Hole Surgery in Combination With Tumor Treating Fields for Glioblastoma: A Computational Study on Dose Optimization and Array Layout PlanningFang Cao, Nikola Mikic, Eric T Wong, et al.Molecular and Clinical Oncology|October 16, 2020
Leukopenia is a biomarker for effective temozolomide dosing and predicts overall survival of patients with glioblastomaK Grace Ho, Erik N Uhlmann, Eric T Wong, et al.The Open Neuroimaging Journal|June 7, 2011
Polyradiculopathies from schwannomatosisYuxia Jia, James A Kraus, Hasini Reddy, et al.Physics in Medicine and Biology|October 13, 2017
End-to-end workflow for finite element analysis of tumor treating fields in glioblastomasJoshua J Timmons, Edwin Lok, Pyay San, et al.Advances in Radiation Oncology|December 9, 2022
Modulation of Tumor-Treating Fields by Cerebral Edema from Brain TumorsEdwin Lok, Matthew Clark, Olivia Liang, et al.Journal of Visualized Experiments : Jove|May 7, 2019
The Clinical Application of Tumor Treating Fields Therapy in GlioblastomaMercedes M Riley, Pyay San, Edwin Lok, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
Bevacizumab for recurrent glioblastoma multiforme: a meta-analysisEric T Wong, Shiva Gautam, Christopher Malchow, et al.BMC Cancer|November 24, 2016
Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomasEric T Wong, Joshua Timmons, Amy Callahan, et al.Case Reports in Oncology|December 1, 2025
Recurrent High-Risk Neuroblastoma in an Adult Woman 28 Years following Curative TreatmentHetal Mistry, Michael Kritselis, Jared S Fridley, et al.Pageof 13